KHALID; SANIA SALEEM; MOHAMMAD EYAN KHAN; UNAIZA NASIR; ASMA RASOOL PEERZADA; MUHAMMAD USMAN BABAR; FAIZAN BANARAS. ROLE OF SGLT-2 INHIBITORS (GLIFLOZINS) AND CARDIORENAL OUTCOME IN PATIENTS WITH OR WITHOUT DIABETES. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 30, n. 18, p. 1001–1009, 2023. DOI: 10.53555/jptcp.v30i18.3220. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/3220. Acesso em: 21 feb. 2024.